In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations
- 1 April 2014
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 19 (4), 400-412
- https://doi.org/10.1016/j.drudis.2013.10.001
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gelEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Bioresponsive matrices in drug deliveryJournal of Biological Engineering, 2010
- Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infectionsJournal of Applied Microbiology, 2010
- Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug DeliveryJournal of Young Pharmacists, 2010
- Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma EfficacyAAPS PharmSciTech, 2010
- Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymersActa Pharmaceutica, 2010
- Carbopol/Chitosan Based pH Triggered In Situ Gelling System for Ocular Delivery of Timolol MaleateScientia Pharmaceutica, 2010
- Engineered polymers for advanced drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Hydrogel biomaterials: A smart future?Biomaterials, 2007
- Ocular absorption and distribution of bendazac after topical administration to rabbits with different vehiclesLife Sciences, 1994